CRESTAR FOR OESTRUS CONTROL IN BREEDING CATTLE

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:

NORGESTOMET; NORGESTOMET; OESTRADIOL VALERATE

Available from:

Intervet Australia Pty Limited

INN (International Name):

norgestomet(1.5mg/mL)+oestradiol valerate(2.5mg/mL)

Pharmaceutical form:

PARENTERAL IMPLANT, DEVICE

Composition:

NORGESTOMET STEROID-ANABOLIC Active 3.0 mg/Im; NORGESTOMET STEROID-ANABOLIC Active 3.0 mg/2mL; OESTRADIOL VALERATE STEROID-ESTROGEN Active 5.0 mg/2mL

Units in package:

5 Doses

Class:

VM - Veterinary Medicine

Manufactured by:

INTERVET AUSTRALIA

Therapeutic group:

CATTLE - BEEF | DAIRY CATTLE | DAIRY CATTLE DRY | HEIFER (YOUNG FEMALE CATTLE) | BOVINE | BREEDERS | BULLOCKS | BULLS | CALVES |

Therapeutic area:

ENDOCRINE SYSTEM

Therapeutic indications:

CONTROL OF OESTRUS | SYNCHRONISATION OF OESTRUS

Product summary:

Poison schedule: 4; Withholding period: WHP: Meat: DO NOT USE less than 51 days before slaughter for human consumption . Milk: DO NOT USE in cows where milk o r milk products may be used for human consumption.; Host/pest details: CATTLE - BEEF: [CONTROL OF OESTRUS, SYNCHRONISATION OF OESTRUS]; DAIRY CATTLE: [CONTROL OF OESTRUS, SYNCHRONISATION OF OESTRUS]; DAIRY CATTLE DRY: [CONTROL OF OESTRUS, SYNCHRONISATION OF OESTRUS]; HEIFER (YOUNG FEMALE CATTLE): [CONTROL OF OESTRUS, SYNCHRONISATION OF OESTRUS]; Poison schedule: 4; Withholding period: ; Host/pest details: CATTLE - BEEF: [CONTROL OF OESTRUS, SYNCHRONISATION OF OESTRUS]; DAIRY CATTLE: [CONTROL OF OESTRUS, SYNCHRONISATION OF OESTRUS]; DAIRY CATTLE DRY: [CONTROL OF OESTRUS, SYNCHRONISATION OF OESTRUS]; HEIFER (YOUNG FEMALE CATTLE): [CONTROL OF OESTRUS, SYNCHRONISATION OF OESTRUS]; For oestrus control in beef breeding cattle, maiden dairy heifers & dry (non-lactating) dairy cows in order to apply a planned insemination program.See LIMITATIONS on label

Authorization status:

Stopped

Authorization date:

2021-07-01

Patient Information leaflet

                                directions for use:
read the enclosed leaflet and blister pack before using this product.
withholding period:
Meat: do not use less than 51 days before slaughter for human
consumption.
Milk: do not use in cows where milk or milk products may be used for
human consumption.
trade adVice:
EXPORT SLAUGHTER INTERVAL (ESI): This product does not have an ESI
established. For advice on the ESI, contact the manufacturer on
1800 033 461 before using this product.
warrantY
Intervet Australia Pty Ltd (IAPL) warrants that this product is of
merchantable quality and fit for its intended purpose. IAPL's
liability for
any loss, including consequential losses or injury caused by act or
omission, including negligent acts or omissions, by IAPL or its agent,
is limited to replacing or repairing the product at the option of
IAPL. If possible, a sample of any product causing concern should be
retained or delivered to IAPL within 30 days for a scientific
examination.
first aid: if poisoning occurs, contact a doctor or poisons
information centre. phone 13 11 26.
Storage:
Store below 25°C (Air conditioning). Protect from light and moisture.
DISPoSaL:
Implants must be collected after removal for disposal by incineration.
Dispose of empty container, outer packaging or
expired product by wrapping with paper and putting in garbage.
APVMA Approval No.: 48149/25D/0909
INTERVET AUSTRALIA PTy LIMITED
91-105 Harpin Street
BENDIGO EAST VIC 3550
Phone: (03) 54409888
Fax: (03) 5442 3162
LIMItatIoNS:
This product is for use in breeding cattle only. Not for use in food
producing animals including cows producing milk for
human consumption and feedlot cattle.
CRESTAR
®
is not a cure and should be used only in healthy animals.
This product must not be used where contamination of milk is likely.
Cows should not be treated until at least 45 days after the last
calving. Heifers to be treated should have reached at least
65-70% of their adult weight and should be at least 15-20 months of
age depending on breed.
The animals should be well fed and in good co
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                PRODUCT NAME: CRESTAR FOR OESTRUS CONTROL IN BREEDING CATTLE
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JULY, 2009
PAGE: 1 OF 6
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: 1 800 033 461
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
Hormone preparation in a suitable vehicle.
TRADE NAME:
CRESTAR FOR OESTRUS CONTROL IN BREEDING CATTLE
PRODUCT CODE:
22184
OTHER NAMES:
This MSDS is intended for both the Implant and the Injectable version
of this product.
RECOMMENDED USE:
A subcutaneous implant and injection for use in cattle for oestrus
synchronisation.
APVMA NO:
48149
CREATION DATE:
November, 2006
THIS VERSION ISSUED:
July, 2009
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Xn, Harmful. Hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
R21/22. Harmful in contact with skin and if swallowed.
SAFETY PHRASES:
S20, S24, S37, S45. When using, do not eat or drink. Avoid contact
with skin. Wear suitable gloves.
In case of accident or if you feel unwell, contact a doctor or Poisons
Information Centre immediately (show the label
where possible).
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
Light yellow oil/Small white cylinder.
ODOUR:
Mild sesame oil odour/No odour.
MAJOR HEALTH HAZARDS:
harmful in contact with skin, and if swallowed.
Norgestomet has low toxicity but is a potential progestagen and can be
skin or gut absorbed. The following is recorded
as general properties of progestagens:
SIDE EFFECTS
: Gastro-intestinal disturbances, acne, fluid retention, weight gain,
allergic skin rashes or urticaria, mental
depression, breast changes, libido changes, altered liver function and
rarely, jaundice.
PRECAUTIONS:
Mentioned for humans are cautions with pre-existing
                                
                                Read the complete document